Mustang Bio (MBIO) Accounts Payables (2015 - 2026)

Mustang Bio (MBIO) has reported Accounts Payables for 12 consecutive years, with $5.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accounts Payables fell 28.29% year-over-year to $5.4 million in Q2 2026; TTM through Jun 2026 was $5.4 million, a 28.29% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, down 42.96% from the prior year.
• Accounts Payables was $5.4 million for Q2 2026 at Mustang Bio, up from $5.3 million in the prior quarter.
• Over five years, Accounts Payables peaked at $15.0 million in Q1 2024 and troughed at $5.3 million in Q1 2026.
• A 5-year average of $10.3 million and a median of $10.8 million in 2022 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables jumped 76.29% in 2022 and tumbled 44.47% in 2025, its largest moves.
• Over 5 years, Accounts Payables stood at $13.7 million in 2022, then gained by 2.08% to $14.0 million in 2023, then sank by 32.33% to $9.5 million in 2024, then plunged by 42.96% to $5.4 million in 2025, then dropped by 0.61% to $5.4 million in 2026.
• The last three Accounts Payables figures came in at $5.4 million (Q2 2026), $5.3 million (Q1 2026), and $5.4 million (Q4 2025), per Business Quant data.